{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:22:59Z","timestamp":1786990979616,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81603122"],"award-info":[{"award-number":["81603122"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.intimp.2019.02.018","type":"journal-article","created":{"date-parts":[[2019,2,16]],"date-time":"2019-02-16T05:05:04Z","timestamp":1550293504000},"page":"9-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Interleukin-33 prevents the development of autoimmune diabetes in NOD mice"],"prefix":"10.1016","volume":"70","author":[{"given":"Jingli","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2019.02.018_bb0005","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jaut.2016.03.011","article-title":"Regulatory T cell therapy for type 1 diabetes: may the force be with you","volume":"71","author":"Gitelman","year":"2016","journal-title":"J. Autoimmun."},{"issue":"10","key":"10.1016\/j.intimp.2019.02.018_bb0010","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s00125-017-4377-1","article-title":"Regulatory T cell dysfunction in type 1 diabetes: what's broken and how can we fix it?","volume":"60","author":"Hull","year":"2017","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.intimp.2019.02.018_bb0015","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/imm.12065","article-title":"Transient depletion of CD4+ CD25+ regulatory T cells results in multiple autoimmune diseases in wild-type and B-cell-deficient NOD mice","volume":"139","author":"Ellis","year":"2013","journal-title":"Immunology"},{"issue":"9","key":"10.1016\/j.intimp.2019.02.018_bb0020","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1084\/jem.20100209","article-title":"IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells","volume":"207","author":"Grinberg-Bleyer","year":"2010","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.intimp.2019.02.018_bb0025","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S2213-8587(13)70113-X","article-title":"Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1\/2 randomised, double-blind, placebo-controlled trial","volume":"1","author":"Hartemann","year":"2013","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"9","key":"10.1016\/j.intimp.2019.02.018_bb0030","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.2337\/dc12-0038","article-title":"Administration of CD4+CD25highCD127- regulatory T cells preserves beta-cell function in type 1 diabetes in children","volume":"35","author":"Marek-Trzonkowska","year":"2012","journal-title":"Diabetes Care"},{"issue":"7519","key":"10.1016\/j.intimp.2019.02.018_bb0035","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature13577","article-title":"The alarmin IL-33 promotes regulatory T-cell function in the intestine","volume":"513","author":"Schiering","year":"2014","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.intimp.2019.02.018_bb0040","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/ni.3085","article-title":"The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells","volume":"16","author":"Vasanthakumar","year":"2015","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2019.02.018_bb0045","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.it.2016.03.007","article-title":"IL-33 in T cell differentiation, function, and immune homeostasis","volume":"37","author":"Peine","year":"2016","journal-title":"Trends Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2019.02.018_bb0050","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.4049\/jimmunol.1400481","article-title":"IL-33 is an unconventional alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R\/ST2+ regulatory T cells","volume":"193","author":"Matta","year":"2014","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2019.02.018_bb0055","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41590-018-0067-5","article-title":"Environmental allergens induce allergic inflammation through proteolytic maturation of IL-33","volume":"19","author":"Cayrol","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2019.02.018_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14919","article-title":"IL-33 contributes to sepsis-induced long-term immunosuppression by expanding the regulatory T cell population","volume":"8","author":"Nascimento","year":"2017","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.intimp.2019.02.018_bb0065","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.immuni.2017.10.015","article-title":"Interleukin-33-activated islet-resident innate lymphoid cells promote insulin secretion through myeloid cell retinoic acid production","volume":"47","author":"Dalmas","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2019.02.018_bb0070","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.3389\/fimmu.2018.02646","article-title":"IL-33 prevents MLD-STZ induction of diabetes and attenuate insulitis in prediabetic NOD mice","volume":"9","author":"Pavlovic","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2019.02.018_bb0075","doi-asserted-by":"crossref","DOI":"10.1038\/srep14593","article-title":"TAK1 inhibition prevents the development of autoimmune diabetes in NOD mice","volume":"5","author":"Cao","year":"2015","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.intimp.2019.02.018_bb0080","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrc.2017.86","article-title":"Targeting immunosuppressive adenosine in cancer","volume":"17","author":"Vijayan","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.intimp.2019.02.018_bb0085","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/CIRCRESAHA.110.218867","article-title":"Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice","volume":"107","author":"Miller","year":"2010","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.intimp.2019.02.018_bb0090","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrc3215","article-title":"The insulin and insulin-like growth factor receptor family in neoplasia: an update","volume":"12","author":"Pollak","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2019.02.018_bb0095","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2337\/db07-1287","article-title":"Electronegative LDL impairs vascular endothelial cell integrity in diabetes by disrupting fibroblast growth factor 2 (FGF2) autoregulation","volume":"57","author":"Lu","year":"2008","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.intimp.2019.02.018_bb0100","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/ATVBAHA.110.206425","article-title":"Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A","volume":"30","author":"Oeseburg","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"Suppl. 1","key":"10.1016\/j.intimp.2019.02.018_bb0105","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/dom.13031","article-title":"Signals in the pancreatic islet microenvironment influence beta-cell proliferation","volume":"19","author":"Aamodt","year":"2017","journal-title":"Diabetes Obes. Metab."},{"issue":"1","key":"10.1016\/j.intimp.2019.02.018_bb0110","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/imr.12619","article-title":"Interleukin-33 (IL-33): a nuclear cytokine from the IL-1 family","volume":"281","author":"Cayrol","year":"2018","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.intimp.2019.02.018_bb0115","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nri2692","article-title":"Disease-associated functions of IL-33: the new kid in the IL-1 family","volume":"10","author":"Liew","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2019.02.018_bb0120","doi-asserted-by":"crossref","unstructured":"C.C. Chen, T. Kobayashi, K. Iijima, F.C. Hsu, H. Kita, IL-33 dysregulates regulatory T cells and impairs established immunologic tolerance in the lungs, J. Allergy Clin. Immunol. 140(5) (2017) 1351\u20131363 e7.","DOI":"10.1016\/j.jaci.2017.01.015"},{"issue":"4","key":"10.1016\/j.intimp.2019.02.018_bb0125","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1182\/blood-2006-12-064527","article-title":"Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression","volume":"110","author":"Borsellino","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.intimp.2019.02.018_bb0130","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1084\/jem.20062512","article-title":"Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression","volume":"204","author":"Deaglio","year":"2007","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.intimp.2019.02.018_bb0135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/imr.12528","article-title":"The ectonucleotidases CD39 and CD73: novel checkpoint inhibitor targets","volume":"276","author":"Allard","year":"2017","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.intimp.2019.02.018_bb0140","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nm.3868","article-title":"Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-alpha","volume":"21","author":"Mascanfroni","year":"2015","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.intimp.2019.02.018_bb0145","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nm0402-358","article-title":"CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness","volume":"8","author":"Mizumoto","year":"2002","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.intimp.2019.02.018_bb0150","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nrd2660","article-title":"The IL-33\/ST2 pathway: therapeutic target and novel biomarker","volume":"7","author":"Kakkar","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.intimp.2019.02.018_bb0155","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1182\/blood-2015-12-684142","article-title":"Peri-alloHCT IL-33 administration expands recipient T-regulatory cells that protect mice against acute GVHD","volume":"128","author":"Matta","year":"2016","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.intimp.2019.02.018_bb0160","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1182\/blood-2006-09-047563","article-title":"Activation of MAP kinase p38 is critical for the cell-cycle-controlled suppressor function of regulatory T cells","volume":"109","author":"Adler","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2019.02.018_bb0165","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.3389\/fimmu.2018.01556","article-title":"The p38 MAPK inhibitor SB203580 abrogates tumor necrosis factor-induced proliferative expansion of mouse CD4(+)Foxp3(+) regulatory T cells","volume":"9","author":"He","year":"2018","journal-title":"Front. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918309470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918309470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T13:46:27Z","timestamp":1565185587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576918309470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":33,"alternative-id":["S1567576918309470"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2019.02.018","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-33 prevents the development of autoimmune diabetes in NOD mice","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2019.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}